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LETTER TO THE EDITOR
Venous thromboembolism in the Chinese population—
experience in a regional hospital in Hong Kong
To the Editor—We note with interest the recent publication
“Venous thromboembolism in the Chinese population—
experience in a regional hospital in Hong Kong”.1 The
authors mentioned that the use of thrombophilic screening
tests were limited, partly due to financial constraints and
partly due to the low frequency of the condition in Chinese
people. Based on these data, however, of the 16 selected
patients tested, six had hereditary thrombophilia (either
protein C or protein S deficiency) and four had lupus anti-
coagulant (LA).1 Hence, hereditary thrombophilia was
detected in 37.5% (6/16) of patients and, overall, 62.5%
(10/16) of patients had thrombophilia. Moreover, in a previ-
ous study conducted locally, of the 52 consecutive Chinese
patients with documented venous thrombosis, 25 had
hereditary thrombophilia (either antithrombin, protein C, or
protein S deficiency) and five had LA and/or anticardiolipin
antibodies.2 This accounts for a prevalence rate for heredi-
tary thrombophilia of 48% (25/52) with an overall rate of
58% (30/52) with thrombophilia. This suggests a high inci-
dence of thrombophilia detected in selected groups of
patients. Although we agree with Liu et al1 that thrombo-
philic testing is expensive, screening is justified to identify
at-risk patients who will receive appropriate prophylactic
anticoagulation and advice aimed at prevention of recurrent
thromboembolism. We recommend that thrombophilic
screening should be performed, at least for selected patient
groups such as those with spontaneous venous thrombo-
embolism, thrombosis occurring at unusual sites or recur-
rent thrombosis, young age of onset (younger than 45 years
old), and family history of thrombosis.3
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